Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday, marking the end of the Bluebird's fall from the one of the buzziest biotec… [+3203 chars]
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker - CNBC
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
By:Angelica Peebles
Source:CNBC
Published:
Related News
business
business
business
Lagarde Abruptly Exited Davos Dinner as Lutnick Berated Europe - The Wall Street Journal
The Wall Street Journal•The Wall Street Journal
US Pending-Home Sales Plunge by Most Since Start of Pandemic - Bloomberg.com
Pending sales of US existing homes fell in December by the most since April 2020, an unusually large drop after the housing market appeared to be gaining some momentum.
Bloomberg•Julia Fanzeres
Elon Musk’s latest feud is a mudslinging match with a budget airline - The Washington Post
The billionaire has been trading online barbs for days with Ryanair in a spat that started over the airline’s refusal to install Starlink. Ryanair has been leaning into it.
The Washington Post•Jennifer Hassan